Immunolocalization of human p14ARF to the granular component of the interphase nucleolus

被引:74
作者
Lindström, MS
Klangby, U
Inoue, R
Pisa, P
Wiman, KG [1 ]
Asker, CE
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[2] Karolinska Hosp, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden
关键词
p14(ARF); nucleolus; p53; senescence; actinomycin D;
D O I
10.1006/excr.2000.4854
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human p14(ARF) protein is encoded by an alternative transcript from the INK4a/ARF locus on chromosome 9p21, a locus frequently afflicted in human tumors. By use of two novel specific antisera against p14(ARF) we show that the protein is localized mainly in nucleoli but also in the nucleoplasm. Transfection of full-length and deletion mutant GFP-p14(ARF) fusion proteins confirmed this subcellular localization and assigned the nucleolar localization signal to the exon 2-encoded C-terminal region. In order to determine p14(ARF) expression in human tumor cells, we examined p14(ARF) in 32 tumor cell lines by immunofluorescence staining. Nucleolar p14(ARF) was detected in 10 lines, all of which lacked functional p53. Double immunostaining with p14(ARF) and B23/nucleophosmin or fibrillarin antibodies using 3D microscopy revealed that p14(ARF) is located mainly in the granular component of the nucleolus. p14(ARF) was also found in distinct granular aggregates scattered throughout the nucleoplasm. RNase digestion or selective inhibition of rRNA transcription by low doses of actinomycin D caused nucleoplasmic translocation of p14(ARF). This indicates that the nucleolar localization of p14(ARF) is dependent on ongoing transcriptional activity in intact functional nucleoli. (C) 2000 Academic Press.
引用
收藏
页码:400 / 410
页数:11
相关论文
共 55 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[3]   GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE [J].
CHEN, PL ;
CHEN, YM ;
BOOKSTEIN, R ;
LEE, WH .
SCIENCE, 1990, 250 (4987) :1576-1580
[4]   E1A signaling to p53 involves the p19ARF tumor suppressor [J].
de Stanchina, E ;
McCurrach, ME ;
Zindy, F ;
Shieh, SY ;
Ferbeyre, G ;
Samuelson, AV ;
Prives, C ;
Roussel, MF ;
Sherr, CJ ;
Lowe, SW .
GENES & DEVELOPMENT, 1998, 12 (15) :2434-2442
[5]   The human protein p19(ARF) is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16(INK4a)/MTS1 gene [J].
DellaValle, V ;
Duro, D ;
Bernard, O ;
Larsen, CJ .
ONCOGENE, 1997, 15 (20) :2475-2481
[6]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[7]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[8]   P53 IS FREQUENTLY MUTATED IN BURKITTS-LYMPHOMA CELL-LINES [J].
FARRELL, PJ ;
ALLAN, GJ ;
SHANAHAN, F ;
VOUSDEN, KH ;
CROOK, T .
EMBO JOURNAL, 1991, 10 (10) :2879-2887
[9]   P53 MUTATIONS IN HUMAN LYMPHOID MALIGNANCIES - ASSOCIATION WITH BURKITT-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
GAIDANO, G ;
BALLERINI, P ;
GONG, JZ ;
INGHIRAMI, G ;
NERI, A ;
NEWCOMB, EW ;
MAGRATH, IT ;
KNOWLES, DM ;
DALLAFAVERA, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5413-5417
[10]   Cyclin E, a redundant cyclin in breast cancer [J].
GrayBablin, J ;
Zalvide, J ;
Fox, MP ;
Knickerbocker, CJ ;
DeCaprio, JA ;
Keyomarsi, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15215-15220